Edition:
United States

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

2.81USD
10:57am EDT
Change (% chg)

$-0.05 (-1.75%)
Prev Close
$2.86
Open
$2.94
Day's High
$2.97
Day's Low
$2.80
Volume
48,101
Avg. Vol
36,415
52-wk High
$3.30
52-wk Low
$1.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 0.057
FY 2017 Dec '17 0.00 -0.437
Sep '17 0.00 -0.217
Jun '17 0.00 -0.117
Mar '17 0.00 -0.599
FY 2016 Dec '16 0.00 -0.367
Sep '16 0.00 -0.303
Jun '16 0.00 -0.392
Mar '16 0.00 -0.541
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 244.89 34.04
P/E High - Last 5 Yrs. -- 290.95 47.73
P/E Low - Last 5 Yrs. -- 100.14 25.07
Beta -0.30 0.73 0.78
Price to Sales (TTM) -- 249.29 8.22
Price to Book (MRQ) 74.01 23.95 4.29
Price to Tangible Book (MRQ) 74.65 30.87 6.00
Price to Cash Flow (TTM) -- 143.83 22.60
% Owned Institutions 61.60 11.87 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.70
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.18 -6.32
Payout Ratio(TTM) -- 42.00 40.51

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 25.06 5.40
Sales (TTM) vs TTM 1 Yr. Ago -- 135.46 12.76
Sales - 5 Yr. Growth Rate -- 31.25 7.90
EPS (MRQ) vs Qtr. 1 Yr. Ago 109.48 -86.73 41.23
EPS (TTM) vs TTM 1 Yr. Ago 57.03 -- --
EPS - 5 Yr. Growth Rate -- 49.02 8.05
Capital Spending - 5 Yr. Growth Rate -- 36.46 7.36

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.55
Current Ratio (MRQ) 4.14 6.34 3.62
LT Debt to Equity (MRQ) 0.00 22.40 13.12
Total Debt to Equity (MRQ) 0.00 26.77 17.61
Interest Coverage (TTM) -1.44 -137.51 36.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.81 55.04
Gross Margin - 5 Yr. Avg. -- 55.33 52.94
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -163.88 15.76
Operating Margin (TTM) -- -890.63 -0.32
Operating Margin - 5 Yr. Avg. -- -177.36 10.97
Pre-Tax Margin (TTM) -- -785.00 1.62
Pre-Tax Margin - 5 Yr. Avg. -- -180.78 11.14
Net Profit Margin (TTM) -- -778.64 -1.66
Net Profit Margin - 5 Yr. Avg. -- -179.59 7.49
Effective Tax Rate (TTM) -- 15.47 29.83
Effective Tax Rate - 5 Yr. Avg. -- 19.38 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,870,457 728,113,809
Net Income/Employee (TTM) -- -128,268 84,561,813
Receivable Turnover (TTM) -- 18.25 6.05
Inventory Turnover (TTM) -- 2.86 3.66
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -102.45 -3.57 10.33
Return on Assets - 5 Yr. Avg. -197.07 -0.69 11.01
Return on Investment (TTM) -133.83 -5.30 13.11
Return on Investment - 5 Yr. Avg. -320.23 2.14 14.30
Return on Equity (TTM) -2,093.40 -6.83 15.11
Return on Equity - 5 Yr. Avg. -506.98 -2.87 15.65
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 11.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellerophon Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 21.70 20.21 99 78
13 Week 48.19 45.22 99 43
26 Week 23.28 19.35 99 88
52 Week 113.43 87.96 99 90
YTD 10.85 7.10 99 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 61.60%
# of Holders: 37
Total Shares Held: 35,401,940
3 Mo. Net Change: 358,551
# New Positions: 8
# Closed Positions: 5
# Increased Positions: 13
# Reduced Positions: 9
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.